Significant bacteriuria among requested repeat urine samples and its clinical correlation
Background and Objectives: Urinary tract infections (UTI) are the most common bacterial infections in both outpatient and inpatient department received for routine bacterial culture and sensitivity. We looked for significant bacteriuria in requested repeat urine sample after primary urine culture yielded significant growth (>105 CFU/ml) of ≥3 types of colonies. Also studied, different isolates grown with their sensitivity pattern and contamination rates of urine samples from different departments.
Materials and Methods: In routine, primary urine cultures yielding ≥3 types of colonies on Cystine Lactose Electrolyte Deficient (C.L.E.D) were requested for repeat samples, collected with aseptic precautions after proper instructions. Data was analyzed for the Microbiological profile and its clinical correlation.
Results: Among 617 received requested urine samples, 292 (47.3%) yielded significant bacteriuria. Clinical details were available for 252 cases out of which 100 (39.7%) showed asymptomatic bacteriuria, 87 (34.5%) complicated UTI and 65 (25.7%) uncomplicated UTI. Null hypothesis was rejected as 292 (47.3%) of the received repeat samples showed significant bacteriuria and 325 (53%) showed normal flora/no growth i.e. there is a 50% chance of getting either a positive culture or normal flora/no growth in repeat urine samples after the primary urine culture showed ≥3 types of colonies. It indicates the importance of requesting repeat urine samples for an accurate urine culture report. Male patients were significantly associated with significant bacteriuria and complicated UTI (p= 0.001). Escherichia coli (n=112, 28%) was the most common followed by Klebsiella species (n=66, 16.4%) and Enterococcus species (n=69, 17.2%). 183 (45.6%) isolates were Multi-Drug Resistant (MDR) Gram Negative Bacilli (GNBs), Escherichia coli (50.3%) being most common. Vancomycin Resistant Enterococcus (VRE) (n=8, 2.0%) was also isolated.
Conclusion: Our study justifies the rationale for asking a repeat urine samples which helps in providing an appropriate microbiological report with antibiotic sensitivity pattern, hence preventing unwanted reporting of commensals/contaminants facilitating evidence based therapy.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003;49:53-70.
3. Vasudevan R. Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp 2014;1:42-54.
4. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015;13:269-284.
5. Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J 2016;57:485-490.
6. Burd EM, Kehl KS. A critical appraisal of the role of the clinical microbiology laboratory in the diagnosis of urinary tract infections. J Clin Microbiol 2011;49(4 Suppl):S34-S38.
7. Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathog 2016;2016:4065603.
8. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
9. Lough ME, Shradar E, Hsieh C, Hedlin H. Contamination in adult midstream clean-catch urine cultures in the emergency department: a randomized controlled trial. J Emerg Nurs 2019;45:488-501.
10. Bekeris LG, Jones BA, Walsh MK, Wagar EA. Urine culture contamination: a college of American pathologists Q-Probes study of 127 laboratories. Arch Pathol Lab Med 2008;132:913-917.
11. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis 2010;50:625-663.
12. Cheesebrough M (2005). District laboratory practice in tropical countries part 1. 2nd ed. Cambridge University Press. Cambridge.
13. Garcia LS, Isenberg HD (2010). Clinical microbiology procedures handbook. 3rd ed. ASM Press. Washington DC.
14. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
15. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
16. Hassan SK, Kumar TN, Kishan NR, Neetha K. Laboratory diagnosis of urinary tract infections using diagnostics tests in adult patients. Int J Res Med Sci 2014;2:415-421.
17. Patel HB, Soni ST, Bhagyalaxmi A, Patel NM. Causative agents of urinary tract infections and their antimicrobial susceptibility patterns at a referral center in western India: an audit to help clinicians prevent antibiotic misuse. J Family Med Prim Care 2019;8:154-159.
18. Iregbu KC, Medugu N, Abdullahi N, Aigbe Al, Modibbo IF, Nwajiobi-Princewill PI, et al. Urine culture contamination: a one-year retrospective study at the national hospital, Abuja. African J Clin Exp Microbiol 2013;14:101-104.
19. Biering-Sørensen F, Bagi P, Høiby N. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs 2001;61:1275-1287.
20. Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2001;17:287-292.
21. Clouse K, Shehabi A, Suleimat AM, Faouri S, Khuri-Bulos N, Al Jammal A, et al. High prevalence of group B Streptococcus colonization among pregnant women in Amman, Jordan. BMC Pregnancy Childbirth 2019;19:177.
|Issue||Vol 13 No 5 (2021)|
|Repeat urine samples; Significant bacteriuria; Multidrug resistant; Urinary tract infection|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|